Viewing Study NCT00365768


Ignite Creation Date: 2025-12-24 @ 5:26 PM
Ignite Modification Date: 2026-01-24 @ 4:50 PM
Study NCT ID: NCT00365768
Status: COMPLETED
Last Update Posted: 2016-09-09
First Post: 2006-08-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Sponsor: Columbia University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
None Leukemia View
None Lymphoma View
None Neurotoxicity View
None Peripheral Neuropathy View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II childhood lymphoblastic lymphoma View
None stage III childhood lymphoblastic lymphoma View
None stage II childhood small noncleaved cell lymphoma View
None stage I Wilms tumor View
None stage II Wilms tumor View
None stage III Wilms tumor View
None stage IV Wilms tumor View
None stage V Wilms tumor View
None childhood grade III lymphomatoid granulomatosis View
None childhood diffuse large cell lymphoma View
None childhood immunoblastic large cell lymphoma View
None stage I childhood large cell lymphoma View
None stage I childhood lymphoblastic lymphoma View
None stage I childhood small noncleaved cell lymphoma View
None stage II childhood large cell lymphoma View
None stage III childhood large cell lymphoma View
None stage IV childhood large cell lymphoma View
None stage IV childhood lymphoblastic lymphoma View
None stage IV childhood small noncleaved cell lymphoma View
None childhood Burkitt lymphoma View
None stage III childhood small noncleaved cell lymphoma View
None untreated childhood acute lymphoblastic leukemia View
None childhood nasal type extranodal NK/T-cell lymphoma View
None previously untreated childhood rhabdomyosarcoma View
None localized Ewing sarcoma/PNET View
None metastatic Ewing sarcoma/PNET View
None neurotoxicity View
None peripheral neuropathy View